Acotec Scientific Holdings Limited

Equities

6669

KYG0096M1096

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:07 2024-06-03 am EDT			5-day change	1st Jan Change
7.61 ^HKD	+1.47%		+4.82%	-32.54%

Mar. 27	Acotec Scientific Gets Registration Approval for Micro-Catheter from Chinese Regulator	MT
Mar. 26	Acotec Scientific Holdings Limited Announces Approval for Vericor-RS by PRC National Medical Products Administration	CI

Acotec Scientific Holdings Limited Provides Revenue Guidance for the Year Ended December 31, 2021

January 23, 2022 at 05:09 am EST

Acotec Scientific Holdings Limited provided revenue guidance for the year ended December 31, 2021. For the period the Group expects to record: revenue of approximately RMB 300 million to RMB 303 million, representing an increase of approximately 54.7% to 56.2% as compared to that of the year ended December 31, 2020.

Latest news about Acotec Scientific Holdings Limited

Acotec Scientific Gets Registration Approval for Micro-Catheter from Chinese Regulator	Mar. 27	MT
Acotec Scientific Holdings Limited Announces Approval for Vericor-RS by PRC National Medical Products Administration	Mar. 26	CI
Acotec Scientific Holdings Limited Receives Approval for Yiyan Coronary High-Pressure Dilatation Balloon by Prc National Medical Products Administration	Mar. 26	CI
Acotec Scientific Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Acotec Scientific Gets Nod for Peridge Catheter	Feb. 01	MT
Acotec Scientific Holdings Limited Announces Approval for Peridge by Prc National Medicalproducts Administration	Jan. 31	CI
Acotec Scientific Holdings Limited Announces Change of Principal Place of Business in Hong Kong	Dec. 27	CI
Acotec Scientific Holdings Limited Receives FDA IDE Approval	Nov. 30	CI
Japanese Regulator Grants Registration Approval to Acotec Scientific’s Peripheral Support Catheter	23-09-22	MT
Acotec Scientific’s Microcatheter Vericor-14 Gets Registration Approval in Japan	23-09-06	MT
Acotec Scientific Holdings Limited Announces Approval for Microcatheter Vericor-14 by the Ministry of Health, Labour and Welfare in Japan and Food and Drug Administration of Thailand	23-09-06	CI
Acotec Scientific Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Acotec Scientific Holdings Limited and Boston Scientific Group plc Enter into the Master Collaboration Agreement	23-07-20	CI
Acotec, Controlling Shareholder Sign MOU for Potential Collaboration on Cardiovascular Products	23-06-18	MT
Acotec Scientific Holdings Limited Announces Memorandum of Understanding with Boston Scientific Group plc	23-06-18	CI
Acotec Scientific’s Microcatheter Product Gets Registration Approval in China	23-04-21	MT
Acotec Scientific Holdings Limited Announces Approval for Microcatheter Vericor-14 by the PRC National Medical Products Administration	23-04-20	CI
Acotec Scientific's Angioplasty Device Gets Registration Approval in China	23-04-19	MT
Acotec Scientific Holdings Limited Announces Approval for Acotec Scientific Holdings Limited by the PRC National Medical Products Administration	23-04-19	CI
Chinese Regulator Gives Registration Approval to Acotec Scientific’s Peripheral Aspiration Catheter	23-04-06	MT
Thai Regulator Approves Registration of Acotec's Support Catheter	23-03-28	MT
Acotec Scientific Holdings Limited Announces Approval for Vericor by the Food and Drug Administration of Thailand	23-03-27	CI
Acotec Scientific Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Acotec Scientific Unit to Lease Premises for R&D, Manufacturing	23-03-14	MT
Chinese Regulator Approves Acotec's RT-Zero Product; Shares Slip 4%	23-03-14	MT

Chart Acotec Scientific Holdings Limited

Duration

Period

Chart Acotec Scientific Holdings Limited

More charts

Company Profile

Acotec Scientific Holdings Ltd is a China-based interventional medical device company. The Company focuses on interventional treatment of vascular diseases, involving Drug-coated Balloons (DCB) and Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) etc. The Company has established a product portfolio for five major therapeutic areas, including vascular surgery, cardiology, nephrology, neurology and andrology. The Company's business covers China, Asia, Europe and other countries and regions.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Acotec Scientific Holdings Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

6.946 CNY

Average target price

9.773 CNY

Spread / Average Target

+40.71%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
ACOTEC SCIENTIFIC HOLDINGS LIMITED	-32.54%	301M
SHOCKWAVE MEDICAL, INC.	+75.69%	12.57B
PENUMBRA, INC.	-24.68%	7.34B
MASIMO CORPORATION	+6.22%	6.61B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+12.58%	5.39B
GETINGE AB	-16.23%	4.84B
APT MEDICAL INC.	+26.90%	4.53B
ASAHI INTECC CO., LTD.	-22.63%	3.91B
INARI MEDICAL, INC.	-22.99%	2.91B
NOVOCURE LIMITED	+47.42%	2.37B

Medical Equipment